TOTI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 12.147
EU - Europa 725
AS - Asia 293
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 13.178
Nazione #
US - Stati Uniti d'America 12.145
CN - Cina 225
DE - Germania 165
UA - Ucraina 152
IE - Irlanda 136
IT - Italia 83
GB - Regno Unito 53
SE - Svezia 40
FI - Finlandia 35
KR - Corea 34
FR - Francia 17
RU - Federazione Russa 17
PL - Polonia 9
BR - Brasile 7
VN - Vietnam 7
IN - India 6
JP - Giappone 6
RO - Romania 4
SG - Singapore 4
TM - Turkmenistan 4
BE - Belgio 3
ES - Italia 3
EU - Europa 3
NL - Olanda 3
AU - Australia 2
CA - Canada 2
CH - Svizzera 2
HK - Hong Kong 2
IL - Israele 2
A1 - Anonimo 1
AT - Austria 1
IQ - Iraq 1
KG - Kirghizistan 1
MD - Moldavia 1
MV - Maldive 1
NO - Norvegia 1
Totale 13.178
Città #
Wilmington 3.370
Woodbridge 3.254
Houston 3.113
Fairfield 431
Ann Arbor 291
Chandler 265
Ashburn 190
Seattle 190
Cambridge 172
Dublin 134
Jacksonville 134
Medford 105
Zhengzhou 81
Beijing 69
Dearborn 65
Lawrence 49
New York 38
Rome 35
San Diego 30
Mülheim 20
Menlo Park 18
Shanghai 15
Creede 12
Nanjing 11
Guangzhou 9
Kraków 9
Mountain View 9
Redwood City 9
Boardman 8
San Mateo 8
Verona 8
Norwalk 7
Nürnberg 7
Falls Church 6
Hefei 6
Helsinki 6
Palo Alto 6
Santa Clara 6
Seoul 6
Kunming 5
Milan 5
São Paulo 5
Chicago 4
Dong Ket 4
Jinan 4
London 4
Nanchang 4
San Francisco 4
Brussels 3
Colorado Springs 3
Detroit 3
Esslingen am Neckar 3
Hangzhou 3
Hounslow 3
Phoenix 3
Saint Petersburg 3
Suceava 3
Hanoi 2
Indiana 2
Islington 2
Kilburn 2
Kwai Chung 2
Los Angeles 2
Madrid 2
New Bedfont 2
Pune 2
Redmond 2
Rozzano 2
Shenyang 2
Tianjin 2
Tokyo 2
Toronto 2
University Park 2
Washington 2
Xian 2
Yinchuan 2
Albano Laziale 1
Amsterdam 1
Augusta 1
Basra 1
Changchun 1
Changsha 1
Charleston 1
Chengdu 1
Chisinau 1
Chiswick 1
Chongqing 1
Dronten 1
Groningen 1
Gunzenhausen 1
Haifa 1
Lappeenranta 1
Latrobe 1
Lausanne 1
Lishui 1
Magenta 1
Malé 1
Mcallen 1
Mestre 1
Miami 1
Totale 12.330
Nome #
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 433
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 424
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 422
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 417
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 416
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 413
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 413
Marginal donors in liver transplantation. 410
Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient 402
Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. 399
Management of spermatic cord liposarcoma in renal transplant recipients: case report 394
Use of mycophenolate mofetil in liver transplantation: a literature review. 392
Liver transplantation in the presence of portal vein thrombosis: report from a single center. 389
Ferguson hemorrhoidectomy with radiofrequency versus classic diathermy 387
596 386
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 382
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 374
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 366
Liver transplantation for the treatment of nodular regenerative hyperplasia 364
Radiofrequency-assisted right hemihepatectomy by using a new incremental bipolar generator combined with liver hanging maneuver. 356
TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKC alpha-ezrin pathway 354
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: A randomized, controlled clinical trial 351
Ferguson Hemorrhoidectomy with Radiofrequency versus Classic Diathermy 345
Submucosal hemorroidectomy with radiofrequency bistoury 335
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. 320
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results 314
Treatment of Multiple Actinic Keratosis and Field of Cancerization with Topical Piroxicam 0.8% and Sunscreen 50+ in Organ Transplant Recipients: A Series of 10 Cases 310
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 309
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 299
An unusual duodenal polyp causing anemia in a liver-transplanted patient 264
Submucosal hemorroidectomy with radiofrequency bistoury 259
Liver transplantation with a normothermic machine preserved fatty nonagenarian liver: A case report 250
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 226
Rare malignant glomus tumor of the stomach with liver metastases 203
Everolimus and enteric-coated mycophenolate sodium Ab initio after liver transplantation: Midterm results 146
Endovascular Mechanical Thromboaspiration of Right Hepatic Arterial Thrombosis After Liver Transplantation 132
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 126
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis 121
Evaluation of Contrast-Enhanced Intraoperative Ultrasound in the Detection and Management of Liver Lesions in Patients with Hepatocellular Carcinoma 118
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 96
Survival after the diagnosis of de novo malignancy in liver transplant recipients 82
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 74
Prevalent use of Combined Prophylaxis of Hepatitis B after liver transplantation in Italy: Results of a national survey in a large cohort 69
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 64
The hamletic dilemma of patients waiting for kidney transplantation during the COVID-19 pandemic: to accept or not to accept (an organ offer)? 33
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 32
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation – a multicenter cohort study 28
Towards tolerance in liver transplantation 22
Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation 16
The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy 16
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 15
The management of immunosuppression in kidney transplant recipients with COVID-19 disease: an update and systematic review of the literature 14
Urological Complications in Kidney Transplant Recipients: Analysis of the Risk Factors and Impact on Transplant Outcomes in the Era of “Extended Criteria Donors” 13
Feasibility and cost effectiveness of ambulatory laparoscopic cholecystectomy. A retrospective cohort study 11
Saline Contrast Echocardiography in Patients With Hepatopulmonary Syndrome Awaiting Liver Transplantation 9
Benign disease and unexpected histologocal findings after pancreaticoduodenectomy: The role of endoscopic ultrasound fine needle aspiration 9
The Enhanced Recovery after Surgery (ERAS) Pathway Is a Safe Journey for Kidney Transplant Recipients during the “Extended Criteria Donor” Era 6
Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study 6
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 5
Totale 13.341
Categoria #
all - tutte 27.288
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019700 0 0 0 0 0 0 0 0 0 0 336 364
2019/20203.764 313 287 245 336 284 354 335 306 348 379 254 323
2020/20212.396 280 301 272 286 227 280 285 252 53 54 69 37
2021/2022501 29 58 12 15 19 53 35 18 46 51 28 137
2022/2023733 67 73 8 88 52 149 55 90 71 11 44 25
2023/2024193 33 11 25 10 31 59 8 2 4 10 0 0
Totale 13.341